Chloroquine and Hydroxychloroquine for the Prevention or Treatment of COVID-19 in Africa: Caution for Inappropriate Off-label Use in Healthcare Settings

The novel severe acute respiratory syndrome-coronavirus-2 pandemic has spread to Africa, where nearly all countries have reported laboratory-confirmed cases of novel coronavirus disease (COVID-19). Although there are ongoing clinical trials of repurposed and investigational antiviral and immune-base...

Descripción completa

Detalles Bibliográficos
Autores principales: Abena, Pascale M., Decloedt, Eric H., Bottieau, Emmanuel, Suleman, Fatima, Adejumo, Prisca, Sam-Agudu, Nadia A., Muyembe TamFum, Jean-Jacques, Seydi, Moussa, Eholie, Serge P., Mills, Edward J., Kallay, Oscar, Zumla, Alimuddin, Nachega, Jean B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The American Society of Tropical Medicine and Hygiene 2020
Materias:
Perspective Piece
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253100/
https://www.ncbi.nlm.nih.gov/pubmed/32323646
http://dx.doi.org/10.4269/ajtmh.20-0290

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7253100/
https://www.ncbi.nlm.nih.gov/pubmed/32323646
http://dx.doi.org/10.4269/ajtmh.20-0290

Ejemplares similares